United States Antimalarial Medication Market Report 2017

Table of Contents

United States Antimalarial Medication Market Report 2017
1 Antimalarial Medication Overview
1.1 Product Overview and Scope of Antimalarial Medication
1.2 Classification of Antimalarial Medication by Product Category
1.2.1 United States Antimalarial Medication Market Size (Sales Volume) Comparison by Type (2012-2022)
1.2.2 United States Antimalarial Medication Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
1.2.3 Resistance
1.2.4 Prevention
1.3 United States Antimalarial Medication Market by Application/End Users
1.3.1 United States Antimalarial Medication Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
1.3.2 Plasmodium Falciparum
1.3.3 Plasmodium Vivax
1.3.4 Plasmodium Malariae
1.3.5 Plasmodium Ovale
1.4 United States Antimalarial Medication Market by Region
1.4.1 United States Antimalarial Medication Market Size (Value) Comparison by Region (2012-2022)
1.4.2 The West Antimalarial Medication Status and Prospect (2012-2022)
1.4.3 Southwest Antimalarial Medication Status and Prospect (2012-2022)
1.4.4 The Middle Atlantic Antimalarial Medication Status and Prospect (2012-2022)
1.4.5 New England Antimalarial Medication Status and Prospect (2012-2022)
1.4.6 The South Antimalarial Medication Status and Prospect (2012-2022)
1.4.7 The Midwest Antimalarial Medication Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Antimalarial Medication (2012-2022)
1.5.1 United States Antimalarial Medication Sales and Growth Rate (2012-2022)
1.5.2 United States Antimalarial Medication Revenue and Growth Rate (2012-2022)

2 United States Antimalarial Medication Market Competition by Players/Suppliers
2.1 United States Antimalarial Medication Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Antimalarial Medication Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Antimalarial Medication Average Price by Players/Suppliers (2012-2017)
2.4 United States Antimalarial Medication Market Competitive Situation and Trends
2.4.1 United States Antimalarial Medication Market Concentration Rate
2.4.2 United States Antimalarial Medication Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Antimalarial Medication Manufacturing Base Distribution, Sales Area, Product Type

3 United States Antimalarial Medication Sales (Volume) and Revenue (Value) by Region (2012-2017)
3.1 United States Antimalarial Medication Sales and Market Share by Region (2012-2017)
3.2 United States Antimalarial Medication Revenue and Market Share by Region (2012-2017)
3.3 United States Antimalarial Medication Price by Region (2012-2017)

4 United States Antimalarial Medication Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
4.1 United States Antimalarial Medication Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Antimalarial Medication Revenue and Market Share by Type (2012-2017)
4.3 United States Antimalarial Medication Price by Type (2012-2017)
4.4 United States Antimalarial Medication Sales Growth Rate by Type (2012-2017)

5 United States Antimalarial Medication Sales (Volume) by Application (2012-2017)
5.1 United States Antimalarial Medication Sales and Market Share by Application (2012-2017)
5.2 United States Antimalarial Medication Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 United States Antimalarial Medication Players/Suppliers Profiles and Sales Data
6.1 GlaxoSmithKline Plc
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Antimalarial Medication Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 GlaxoSmithKline Plc Antimalarial Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Ranbaxy Laboratories
6.2.2 Antimalarial Medication Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Ranbaxy Laboratories Antimalarial Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Zydus Cadila
6.3.2 Antimalarial Medication Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Zydus Cadila Antimalarial Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 Alvizia Health Care
6.4.2 Antimalarial Medication Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Alvizia Health Care Antimalarial Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Bayer AG
6.5.2 Antimalarial Medication Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Bayer AG Antimalarial Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Pfizer, Inc.
6.6.2 Antimalarial Medication Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Pfizer, Inc. Antimalarial Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Ipca Laboratories Ltd
6.7.2 Antimalarial Medication Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Ipca Laboratories Ltd Antimalarial Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Merck KGaA
6.8.2 Antimalarial Medication Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Merck KGaA Antimalarial Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 F. Hoffmann-La Roche AG
6.9.2 Antimalarial Medication Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 F. Hoffmann-La Roche AG Antimalarial Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Novartis AG
6.10.2 Antimalarial Medication Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Novartis AG Antimalarial Medication Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview

7 Antimalarial Medication Manufacturing Cost Analysis
7.1 Antimalarial Medication Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Antimalarial Medication

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Antimalarial Medication Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Antimalarial Medication Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 United States Antimalarial Medication Market Size (Value and Volume) Forecast (2017-2022)
11.1 United States Antimalarial Medication Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Antimalarial Medication Sales Volume Forecast by Type (2017-2022)
11.3 United States Antimalarial Medication Sales Volume Forecast by Application (2017-2022)
11.4 United States Antimalarial Medication Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Antimalarial Medication
Figure United States Antimalarial Medication Market Size (MT) by Type (2012-2022)
Figure United States Antimalarial Medication Sales Volume Market Share by Type (Product Category) in 2016
Figure Resistance Product Picture
Figure Prevention Product Picture
Figure United States Antimalarial Medication Market Size (MT) by Application (2012-2022)
Figure United States Sales Market Share of Antimalarial Medication by Application in 2016
Figure Plasmodium Falciparum Examples
Table Key Downstream Customer in Plasmodium Falciparum
Figure Plasmodium Vivax Examples
Table Key Downstream Customer in Plasmodium Vivax
Figure Plasmodium Malariae Examples
Table Key Downstream Customer in Plasmodium Malariae
Figure Plasmodium Ovale Examples
Table Key Downstream Customer in Plasmodium Ovale
Figure United States Antimalarial Medication Market Size (Million USD) by Region (2012-2022)
Figure The West Antimalarial Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Antimalarial Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Antimalarial Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Antimalarial Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Antimalarial Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Antimalarial Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antimalarial Medication Sales (MT) and Growth Rate (2012-2022)
Figure United States Antimalarial Medication Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Antimalarial Medication Market Major Players Product Sales Volume (MT) (2012-2017)
Table United States Antimalarial Medication Sales (MT) of Key Players/Suppliers (2012-2017)
Table United States Antimalarial Medication Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antimalarial Medication Sales Share by Players/Suppliers
Figure 2017 United States Antimalarial Medication Sales Share by Players/Suppliers
Figure United States Antimalarial Medication Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Antimalarial Medication Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Antimalarial Medication Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Antimalarial Medication Revenue Share by Players/Suppliers
Figure 2017 United States Antimalarial Medication Revenue Share by Players/Suppliers
Table United States Market Antimalarial Medication Average Price (USD/Kg) of Key Players/Suppliers (2012-2017)
Figure United States Market Antimalarial Medication Average Price (USD/Kg) of Key Players/Suppliers in 2016
Figure United States Antimalarial Medication Market Share of Top 3 Players/Suppliers
Figure United States Antimalarial Medication Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Antimalarial Medication Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Antimalarial Medication Product Category
Table United States Antimalarial Medication Sales (MT) by Region (2012-2017)
Table United States Antimalarial Medication Sales Share by Region (2012-2017)
Figure United States Antimalarial Medication Sales Share by Region (2012-2017)
Figure United States Antimalarial Medication Sales Market Share by Region in 2016
Table United States Antimalarial Medication Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Antimalarial Medication Revenue Share by Region (2012-2017)
Figure United States Antimalarial Medication Revenue Market Share by Region (2012-2017)
Figure United States Antimalarial Medication Revenue Market Share by Region in 2016
Table United States Antimalarial Medication Price (USD/Kg) by Region (2012-2017)
Table United States Antimalarial Medication Sales (MT) by Type (2012-2017)
Table United States Antimalarial Medication Sales Share by Type (2012-2017)
Figure United States Antimalarial Medication Sales Share by Type (2012-2017)
Figure United States Antimalarial Medication Sales Market Share by Type in 2016
Table United States Antimalarial Medication Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Antimalarial Medication Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antimalarial Medication by Type (2012-2017)
Figure Revenue Market Share of Antimalarial Medication by Type in 2016
Table United States Antimalarial Medication Price (USD/Kg) by Types (2012-2017)
Figure United States Antimalarial Medication Sales Growth Rate by Type (2012-2017)
Table United States Antimalarial Medication Sales (MT) by Application (2012-2017)
Table United States Antimalarial Medication Sales Market Share by Application (2012-2017)
Figure United States Antimalarial Medication Sales Market Share by Application (2012-2017)
Figure United States Antimalarial Medication Sales Market Share by Application in 2016
Table United States Antimalarial Medication Sales Growth Rate by Application (2012-2017)
Figure United States Antimalarial Medication Sales Growth Rate by Application (2012-2017)
Table GlaxoSmithKline Plc Basic Information List
Table GlaxoSmithKline Plc Antimalarial Medication Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc Antimalarial Medication Sales Growth Rate (2012-2017)
Figure GlaxoSmithKline Plc Antimalarial Medication Sales Market Share in United States (2012-2017)
Figure GlaxoSmithKline Plc Antimalarial Medication Revenue Market Share in United States (2012-2017)
Table Ranbaxy Laboratories Basic Information List
Table Ranbaxy Laboratories Antimalarial Medication Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Ranbaxy Laboratories Antimalarial Medication Sales Growth Rate (2012-2017)
Figure Ranbaxy Laboratories Antimalarial Medication Sales Market Share in United States (2012-2017)
Figure Ranbaxy Laboratories Antimalarial Medication Revenue Market Share in United States (2012-2017)
Table Zydus Cadila Basic Information List
Table Zydus Cadila Antimalarial Medication Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Zydus Cadila Antimalarial Medication Sales Growth Rate (2012-2017)
Figure Zydus Cadila Antimalarial Medication Sales Market Share in United States (2012-2017)
Figure Zydus Cadila Antimalarial Medication Revenue Market Share in United States (2012-2017)
Table Alvizia Health Care Basic Information List
Table Alvizia Health Care Antimalarial Medication Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Alvizia Health Care Antimalarial Medication Sales Growth Rate (2012-2017)
Figure Alvizia Health Care Antimalarial Medication Sales Market Share in United States (2012-2017)
Figure Alvizia Health Care Antimalarial Medication Revenue Market Share in United States (2012-2017)
Table Bayer AG Basic Information List
Table Bayer AG Antimalarial Medication Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Bayer AG Antimalarial Medication Sales Growth Rate (2012-2017)
Figure Bayer AG Antimalarial Medication Sales Market Share in United States (2012-2017)
Figure Bayer AG Antimalarial Medication Revenue Market Share in United States (2012-2017)
Table Pfizer, Inc. Basic Information List
Table Pfizer, Inc. Antimalarial Medication Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Pfizer, Inc. Antimalarial Medication Sales Growth Rate (2012-2017)
Figure Pfizer, Inc. Antimalarial Medication Sales Market Share in United States (2012-2017)
Figure Pfizer, Inc. Antimalarial Medication Revenue Market Share in United States (2012-2017)
Table Ipca Laboratories Ltd Basic Information List
Table Ipca Laboratories Ltd Antimalarial Medication Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Ipca Laboratories Ltd Antimalarial Medication Sales Growth Rate (2012-2017)
Figure Ipca Laboratories Ltd Antimalarial Medication Sales Market Share in United States (2012-2017)
Figure Ipca Laboratories Ltd Antimalarial Medication Revenue Market Share in United States (2012-2017)
Table Merck KGaA Basic Information List
Table Merck KGaA Antimalarial Medication Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Merck KGaA Antimalarial Medication Sales Growth Rate (2012-2017)
Figure Merck KGaA Antimalarial Medication Sales Market Share in United States (2012-2017)
Figure Merck KGaA Antimalarial Medication Revenue Market Share in United States (2012-2017)
Table F. Hoffmann-La Roche AG Basic Information List
Table F. Hoffmann-La Roche AG Antimalarial Medication Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure F. Hoffmann-La Roche AG Antimalarial Medication Sales Growth Rate (2012-2017)
Figure F. Hoffmann-La Roche AG Antimalarial Medication Sales Market Share in United States (2012-2017)
Figure F. Hoffmann-La Roche AG Antimalarial Medication Revenue Market Share in United States (2012-2017)
Table Novartis AG Basic Information List
Table Novartis AG Antimalarial Medication Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017)
Figure Novartis AG Antimalarial Medication Sales Growth Rate (2012-2017)
Figure Novartis AG Antimalarial Medication Sales Market Share in United States (2012-2017)
Figure Novartis AG Antimalarial Medication Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antimalarial Medication
Figure Manufacturing Process Analysis of Antimalarial Medication
Figure Antimalarial Medication Industrial Chain Analysis
Table Raw Materials Sources of Antimalarial Medication Major Players/Suppliers in 2016
Table Major Buyers of Antimalarial Medication
Table Distributors/Traders List
Figure United States Antimalarial Medication Sales Volume (MT) and Growth Rate Forecast (2017-2022)
Figure United States Antimalarial Medication Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Antimalarial Medication Price (USD/Kg) Trend Forecast (2017-2022)
Table United States Antimalarial Medication Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Antimalarial Medication Sales Volume (MT) Forecast by Type (2017-2022)
Figure United States Antimalarial Medication Sales Volume (MT) Forecast by Type in 2022
Table United States Antimalarial Medication Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Antimalarial Medication Sales Volume (MT) Forecast by Application (2017-2022)
Figure United States Antimalarial Medication Sales Volume (MT) Forecast by Application in 2022
Table United States Antimalarial Medication Sales Volume (MT) Forecast by Region (2017-2022)
Table United States Antimalarial Medication Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antimalarial Medication Sales Volume Share Forecast by Region (2017-2022)
Figure United States Antimalarial Medication Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.